| Home > Publications database > Decreased 5‐hydroxymethylcytosine immunoreactivity in primary Merkel cell carcinoma is a strong predictor for disease‐specific deathL401 > print |
| 001 | 148902 | ||
| 005 | 20240229120020.0 | ||
| 024 | 7 | _ | |a 10.1111/bjd.17705 |2 doi |
| 024 | 7 | _ | |a 0007-0963 |2 ISSN |
| 024 | 7 | _ | |a 0366-2845 |2 ISSN |
| 024 | 7 | _ | |a 1365-2133 |2 ISSN |
| 024 | 7 | _ | |a altmetric:54851373 |2 altmetric |
| 024 | 7 | _ | |a pmid:30703276 |2 pmid |
| 037 | _ | _ | |a DKFZ-2020-00060 |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Gambichler, T. |0 0000-0001-7862-3695 |b 0 |
| 245 | _ | _ | |a Decreased 5‐hydroxymethylcytosine immunoreactivity in primary Merkel cell carcinoma is a strong predictor for disease‐specific deathL401 |
| 260 | _ | _ | |a Oxford |c 2019 |b Wiley-Blackwell |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1581516852_22604 |2 PUB:(DE-HGF) |x Letter |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 536 | _ | _ | |a 899 - ohne Topic (POF3-899) |0 G:(DE-HGF)POF3-899 |c POF3-899 |f POF III |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef |
| 700 | 1 | _ | |a Schmitt, Lukas |b 1 |
| 700 | 1 | _ | |a Rüddel, I. |b 2 |
| 700 | 1 | _ | |a Dreibigacker, M. |b 3 |
| 700 | 1 | _ | |a Stockfleth, E. |b 4 |
| 700 | 1 | _ | |a Becker, J. C. |0 P:(DE-HGF)0 |b 5 |
| 773 | _ | _ | |a 10.1111/bjd.17705 |g Vol. 181, no. 2, p. 389 - 390 |0 PERI:(DE-600)2004086-6 |n 2 |p 389 - 390 |t British journal of dermatology |v 181 |y 2019 |x 1365-2133 |
| 909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:148902 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 5 |6 P:(DE-HGF)0 |
| 913 | 1 | _ | |a DE-HGF |b Programmungebundene Forschung |l ohne Programm |1 G:(DE-HGF)POF3-890 |0 G:(DE-HGF)POF3-899 |2 G:(DE-HGF)POF3-800 |v ohne Topic |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |
| 914 | 1 | _ | |y 2019 |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b BRIT J DERMATOL : 2017 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b BRIT J DERMATOL : 2017 |
| 920 | 1 | _ | |0 I:(DE-He78)L401-20160331 |k L401 |l DKTK Essen |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)L401-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|